Skip to main content

PSIL

ETF

Performance overview

PSIL Price
Price Chart

Forward-looking statistics

Beta
1.21
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

Fund info

Investing methodActively Managed
DiversifiedNo
Expense ratio0.75%
Asset classEquities

Company info

Sector
Industry
Website
AUM

Security info

ExchangeNyse American
Type of shareN/A
Earnings per share (EPS)
Dividend per share
Revenue per share
Avg trading volume (30 day)$152K
Avg trading volume (10 day)$111K
Put-call ratioN/A

Macro factor sensitivity

Growth+1.6
Credit+3.5
Liquidity-1.8
Inflation-1.6
Commodities+0.8
Interest Rates-1.7

Upcoming events

Next earnings day
Next dividend day
Ex. dividend dayMarch 21, 2025

News

5 ETFs That Beat the Market in the First Half of 2025

SGDM, SLVP, SHLD, URA and PSIL top the charts in the first half of 2025, defying market turmoil and riding sector-specific surges.

Zacks Investment Research (June 20, 2025)
EXCLUSIVE: Investing In The Unique Growth Market Of Psychedelics - AdvisorShares Psychedelics ETF (ARCA:PSIL)

The global psychedelics market of drugs such as psilocybin, ketamine and LSD is booming and there are plenty of ways to get involved in the space.

Benzinga (April 13, 2023)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage